Skip to content
DefDex

Federal award

HENRY SCHEIN, INC.

HT941023P0219

Contract

Obligated and Ceiling

Obligated (net)
$176,906.95
Ceiling (potential value, not spending)
$309,769.00
Current value
$242,680.78
Gross positive obligations
$180,217.45

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
HENRY SCHEIN, INC. · D6MTSKS115L9
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
HENRY SCHEIN, INC. · D6MTSKS115L9
Awarding agency
Department of War · sub-agency 97DH · office HT9410
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
HT941023P0219
Award type code
B
Actions
11 · Sep 19, 2023 to Jun 3, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History11

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 3, 2026FY2026P00010B$1,806.00
—
Jan 28, 2026FY2026P00009C−$142.95
—
Nov 21, 2025FY2026P00008C$61,253.22
—
Aug 12, 2025FY2025P00007G$0.00
—
Apr 9, 2025FY2025P00006B−$3,167.55
—
Nov 14, 2024FY2025P00005C$60,052.30
—
Sep 18, 2024FY2024P00004G$0.00
—
Jun 5, 2024FY2024P00003B$589.74
—
Mar 25, 2024FY2024P00002B$41,747.68
—
Oct 30, 2023FY2024P00001B$14,768.51
—
Sep 19, 2023FY20230—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.